Meeting Banner
Abstract #2189

Assessment of Response to Anti-angiogenic Targeted Therapy in Pulmonary Metastatic Renal Cell Carcinoma R2 value as a Predictive Biomarker

Guangyu Wu 1 and Jianrong Xu 1

1 Department of Radiology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, , ΟΊ, China

This study was to evaluate the usefulness of magnetic resonance(MR) R2* mapping in assessing response of treatment in patients with pulmonary metastatic renal cell carcinoma receiving anti-angiogenic targeted therapy.

This abstract and the presentation materials are available to members only; a login is required.

Join Here